Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalent Gross Profit 2012-2024 | CTLT

Catalent annual/quarterly gross profit history and growth rate from 2012 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Catalent gross profit for the quarter ending March 31, 2024 was $0.229B, a 27.22% increase year-over-year.
  • Catalent gross profit for the twelve months ending March 31, 2024 was $784M, a 39.08% decline year-over-year.
  • Catalent annual gross profit for 2023 was $1.04B, a 35.56% decline from 2022.
  • Catalent annual gross profit for 2022 was $1.614B, a 19.38% increase from 2021.
  • Catalent annual gross profit for 2021 was $1.352B, a 37.54% increase from 2020.
  
Catalent Annual Gross Profit
(Millions of US $)
2023 $1,040
2022 $1,614
2021 $1,352
2020 $983
2019 $805
2018 $753
2017 $655
2016 $588
2015 $615
2014 $599
2013 $569
2012 $559
2011 $502
Catalent Quarterly Gross Profit
(Millions of US $)
2024-03-31 $229
2023-12-31 $171
2023-09-30 $169
2023-06-30 $215
2023-03-31 $180
2022-12-31 $387
2022-09-30 $258
2022-06-30 $462
2022-03-31 $423
2021-12-31 $405
2021-09-30 $324
2021-06-30 $439
2021-03-31 $366
2020-12-31 $298
2020-09-30 $249
2020-06-30 $334
2020-03-31 $239
2019-12-31 $232
2019-09-30 $178
2019-06-30 $256
2019-03-31 $199
2018-12-31 $201
2018-09-30 $149
2018-06-30 $233
2018-03-31 $192
2017-12-31 $187
2017-09-30 $140
2017-06-30 $215
2017-03-31 $167
2016-12-31 $148
2016-09-30 $124
2016-06-30 $188
2016-03-31 $126
2015-12-31 $152
2015-09-30 $122
2015-06-30 $182
2015-03-31 $152
2014-12-31 $156
2014-09-30 $125
2014-06-30 $190
2014-03-31 $152
2013-12-31 $137
2013-09-30 $119
2013-06-30
2013-03-31
2012-06-30
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.041B $4.276B
Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs (protein, cell, and gene therapy biologics) and consumer health products.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.821B 31.64
Chugai Pharmaceutical (CHGCY) Japan $51.488B 23.01
Takeda Pharmaceutical (TAK) Japan $41.459B 8.40
Merck (MKGAF) Germany $24.092B 23.36
Astellas Pharma (ALPMY) Japan $17.210B 27.17
Sandoz Group AG (SDZNY) Switzerland $15.410B 0.00
Neurocrine Biosciences (NBIX) United States $13.631B 37.31
United Therapeutics (UTHR) United States $12.777B 13.62
Shionogi (SGIOY) Japan $11.322B 9.84
Cerevel Therapeutics Holdings (CERE) United States $7.567B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.118B 7.82
Revolution Medicines (RVMD) United States $6.372B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Ionis Pharmaceuticals (IONS) United States $5.933B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.916B 0.00
Summit Therapeutics (SMMT) United States $5.890B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.575B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.209B 0.00
Corcept Therapeutics (CORT) United States $3.016B 27.33
Dyne Therapeutics (DYN) United States $2.890B 0.00
PTC Therapeutics (PTCT) United States $2.747B 0.00
Indivior (INDV) United States $2.279B 10.80
Recursion Pharmaceuticals (RXRX) United States $2.201B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.127B 12.09
Catalyst Pharmaceuticals (CPRX) United States $1.779B 17.31
NewAmsterdam Pharma (NAMS) Netherlands $1.727B 0.00
Evotec AG (EVO) Germany $1.612B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.606B 24.14
Avadel Pharmaceuticals (AVDL) Ireland $1.520B 0.00
Ardelyx (ARDX) United States $1.478B 0.00
Soleno Therapeutics (SLNO) United States $1.417B 0.00
Pacira BioSciences (PCRX) United States $1.309B 12.45
BioCryst Pharmaceuticals (BCRX) United States $1.273B 0.00
Xencor (XNCR) United States $1.269B 0.00
4D Molecular Therapeutics (FDMT) United States $1.222B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.155B 0.00
Collegium Pharmaceutical (COLL) United States $1.039B 6.22
Centessa Pharmaceuticals (CNTA) United Kingdom $1.023B 0.00
Enliven Therapeutics (ELVN) United States $1.021B 0.00
Relay Therapeutics (RLAY) United States $0.970B 0.00
Cassava Sciences (SAVA) United States $0.946B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.913B 14.22
Cronos Group (CRON) Canada $0.909B 0.00
Ocular Therapeutix (OCUL) United States $0.891B 0.00
USANA Health Sciences (USNA) United States $0.857B 14.01
ARS Pharmaceuticals (SPRY) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.806B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Harrow (HROW) United States $0.636B 0.00
ProKidney (PROK) United States $0.626B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Larimar Therapeutics (LRMR) United States $0.599B 0.00
Silence Therapeutics (SLN) United Kingdom $0.578B 0.00
Lexeo Therapeutics (LXEO) United States $0.573B 0.00
Esperion Therapeutics (ESPR) United States $0.566B 0.00
Savara (SVRA) United States $0.564B 0.00
Heron Therapeutics (HRTX) United States $0.542B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.535B 0.00
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Bioventus (BVS) United States $0.505B 19.33
OmniAb (OABI) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.474B 6.06
Verve Therapeutics (VERV) United States $0.455B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Altimmune (ALT) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Korro Bio (KRRO) United States $0.386B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.344B 0.00
Black Diamond Therapeutics (BDTX) United States $0.336B 0.00
Organogenesis (ORGO) United States $0.331B 62.38
Xeris Biopharma Holdings (XERS) United States $0.326B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Enanta Pharmaceuticals (ENTA) United States $0.272B 0.00
Fractyl Health (GUTS) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.262B 0.00
Century Therapeutics (IPSC) United States $0.259B 0.00
Aquestive Therapeutics (AQST) United States $0.245B 0.00
ESSA Pharma (EPIX) Canada $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.224B 0.00
Acrivon Therapeutics (ACRV) United States $0.224B 0.00
Foghorn Therapeutics (FHTX) United States $0.224B 0.00
Pyxis Oncology (PYXS) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Avita Medical (RCEL) United States $0.216B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Prelude Therapeutics (PRLD) United States $0.214B 0.00
Incannex Healthcare (IXHL) Australia $0.211B 0.00
Metagenomi (MGX) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.185B 225.33
Elite Pharmaceuticals (ELTP) United States $0.180B 16.84
Achieve Life Sciences (ACHV) Canada $0.168B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Cardiol Therapeutics (CRDL) Canada $0.165B 0.00
Telomir Pharmaceuticals (TELO) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.163B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
MediWound (MDWD) Israel $0.139B 0.00
CytoDyn (CYDY) United States $0.133B 0.00
Conduit Pharmaceuticals (CDT) United States $0.133B 0.00
OptiNose (OPTN) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.112B 7.45
Journey Medical (DERM) United States $0.111B 0.00
FibroGen (FGEN) United States $0.111B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.09
Champions Oncology (CSBR) United States $0.068B 0.00
Tempest Therapeutics (TPST) United States $0.064B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
DURECT (DRRX) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
Carisma Therapeutics (CARM) United States $0.047B 0.00
Inotiv (NOTV) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
BioVie (BIVI) United States $0.028B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
SHINECO (SISI) China $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Unicycive Therapeutics (UNCY) United States $0.024B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Minerva Neurosciences (NERV) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
JanOne (JAN) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Alaunos Therapeutics (TCRT) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.12